Product Program year 2020 Source: CMS Open Payments

ForeSight Elite tissue oximetry system

Device Noninvasive Hemodynamic Monitoring

Open in the dashboard

General payments

$25,920

121 payments

Research payments

$0

0 payments

Through program year 2020, $25,920 in general payments and $0 in research payments were reported against ForeSight Elite tissue oximetry system (Noninvasive Hemodynamic Monitoring).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $20,473 72
2019 General $5,447 49

Breakdown

Who paid General payments · program years 2019–2020
  1. Edwards Lifesciences Corporation $25,920 121 payments
Top recipients General payments · program year 2020
  1. St. Francis Hospital & Health Center Teaching hospital · IN $5,325 26% · 2 payments
  2. St. Peters Hospital Teaching hospital · NY $3,328 16% · 2 payments
  3. Community Health Network Inc. Teaching hospital · IN $1,997 10% · 1 payment
  4. Christus Mother Frances Hosp-Tyler Teaching hospital · TX $1,664 8% · 2 payments
  5. Newark Beth Israel Medical Center Teaching hospital · NJ $1,331 7% · 1 payment

The top 5 of 59 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Anesthesiology $2,013 58% · 36 practitioners
  2. Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,000 29% · 8 practitioners
  3. Internal Medicine $138 4% · 1 practitioner
  4. Vascular Neurology Psychiatry & Neurology $137 4% · 1 practitioner
  5. Pediatric Surgery Surgery $105 3% · 1 practitioner

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Indiana $8,321 41% · 3 recipients
  2. New York $3,328 16% · 1 recipient
  3. New Jersey $2,330 11% · 2 recipients
  4. Texas $1,718 8% · 3 recipients
  5. Arkansas $1,331 7% · 1 recipient

The top 5 of 15 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

121 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record